Total
0
Shares
Opyl (ASX:OPL) - CEO, Michelle Gallaher
CEO, Michelle Gallaher
Sourced: Startup Daily
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Opyl (OPL) and the Association of Australian Medical Research Institutes have launched a social media guide to support medical researchers during COVID-19
  • Opyl has seen a 188 per cent increase in pandemic-related research findings being shared, as well as a 61 per cent increase in social media engagement since April
  • Opyl and AAMRI’s comprehensive guide will ensure that users are getting the right information from credible and knowledgeable sources
  • Company shares closed in the grey, trading for 7.3 cents each

Opyl (OPL) and the Association of Australian Medical Research Institutes (AAMRI) have launched a social media guide to support medical researchers during COVID-19.

Opyl is a social media technology company that specialises in the health and life-sciences industries.

Since the outbreak of COVID-19, Opyl has been monitoring online platforms. During this time, it has noted a 188 per cent increase in pandemic-related clinical and research findings being discussed and shared by medical researchers and healthcare professionals. Professionals in these fields have also been spending more time on social media sites than before.

According to Opyl, COVID-19 has seen a 61 per cent increase in social media engagement since the beginning of April.

“The need to disseminate trustworthy medical research, both quickly and broadly, has never been greater,” the company stated.

“It’s vital that Australian researchers know how to promote their research beyond the journals and ensure the new knowledge they’re creating gets noticed by a global audience. I hope our support helps Australian research go viral — for all the right reasons,” Opyl CEO Michelle Gallaher said.

Opyl and AAMRI’s comprehensive guide will ensure that users are getting the right information from credible and knowledgeable sources.

“For medical research institutes this is a real opportunity to share our knowledge and also demonstrate the huge amount of work we are undertaking for COVID-19 across Australia,” AAMRI President Professor Jonathan Carapetis AM said.

Company shares closed in the grey, trading for 7.3 cents each.

OPL by the numbers
More From The Market Herald

" Rhinomed (ASX:RNO) receives ethics approval for Rhinoswab trial

Wearable nasal and respiratory company Rhinomed (RNO) has received ethics approval to undertake a clinical trial of Rhinoswab at St Vincents Hospital in
Security Matters (ASX:SMX) - CEO, Haggai Alon

" Security Matters (ASX:SMX) increases customer receipts in Q3

Security Matters (SMX) has delivered a recap of its quarterly activities during the three months ending September 30 2021.
The Market Herald Video

" Identitii (ASX:ID8) raises $6m to pursue growth initiatives

Software firm Identitii (ID8) has raised $6 million in a placement to institutional investors as it looks to accelerate a number of current
Silex Systems (ASX:SLX) - Managing Director & CEO, Michael Goldsworthy

" Silex Systems (ASX:SLX) completes $7m capital raise

Technology researcher and developer Silex Systems (SLX) has completed a share purchase plan (SPP) to raise $7 million.